PubAg

Main content area

The Eye, Oxidative Damage and Polyunsaturated Fatty Acids

Author:
Saccà, Sergio Claudio, Cutolo, Carlo Alberto, Ferrari, Daniele, Corazza, Paolo, Traverso, Carlo Enrico
Source:
Nutrients 2018 v.10 no.6
ISSN:
2072-6643
Subject:
antioxidant activity, chronic exposure, drug therapy, endothelial cells, eyes, free radicals, glaucoma, homeostasis, ionizing radiation, light, macular degeneration, mitochondria, oxidative stress, oxygen, polyunsaturated fatty acids, risk assessment, tissues, toxins, ultraviolet radiation
Abstract:
Polyunsaturated fatty acids (PUFA) are known to have numerous beneficial effects, owing to their anti-inflammatory and antioxidant properties. From a metabolic standpoint, the mitochondria play a fundamental role in cellular homeostasis, and oxidative stress can affect their functioning. Indeed, the mitochondria are the main source of ROS, and an imbalance between ROS and antioxidant defenses leads to oxidative stress. In addition, aging, the decline of cellular functions, and continual exposure to light underlie many diseases, particularly those of the eye. Long-term exposure to insults, such as UV light, visible light, ionizing radiation, chemotherapeutics, and environmental toxins, contribute to oxidative damage in ocular tissues and expose the aging eye to considerable risk of pathological consequences of oxidative stress. Ample antioxidant defenses responsible for scavenging free radicals are essential for redox homeostasis in the eye, indeed, eye tissues, starting from the tear film, which normally are exposed to high oxygen levels, have strong antioxidant defenses that are efficient for protecting against ROS-related injuries. On the contrary, instead, the trabecular meshwork is not directly exposed to light and its endothelial cells are poorly equipped with antioxidant defenses. All this makes the eye a target organ of oxidative damage. This review focuses on the role of the polyunsaturated fatty acids in the human eye, particularly in such pathologies as dry eye, glaucoma, and macular degeneration, in which dietary PUFA supplementation can be a valid therapeutic aid.
Agid:
6502974